Harmony Biosciences announced that Jeffrey Dayno, M.D., has been appointed President and CEO by the company’s Board of Directors and has been elected to join as a member of the Board. Dayno joined Harmony as Chief Medical Officer and Executive Vice President when the company was founded in 2017 and has been serving as Interim President and CEO since January 6, 2023. With the appointment, Aronin returns to serving as non-executive Chairman of the Board.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HRMY:
- BofA starts Harmony Biosciences at Neutral, sees downside risk to consensus
- Harmony Biosciences initiated with a Neutral at BofA
- Harmony in ‘first innings of its valuation rebound,’ says Oppenheimer
- Harmony Biosciences reports accelerated timeline for Phase 3 hypersomnia study
- Harmony short report ‘misleading,’ ‘perhaps even sensational,’ says Mizuho
